DNTH 8-K 2026-01-12

Dianthus Therapeutics, Inc. /DE/ (DNTH) 8-K dated 2026-01-12 — accession 0001193125-26-009898. This URL is the filing, not the DNTH hub.

Dianthus Therapeutics, Inc. /DE/ (DNTH) is a biotechnology company listed on US.

Dianthus Therapeutics, Inc. /DE/ filed a 8-K on 2026-01-12. Accession 0001193125-26-009898.

Cached items: 2.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported DNTH revenue for 2026-06-30 was $17.8M. Net income was -$91.0M. DNTH currently screens at market cap $4.40B.

Not investment advice. The DNTH SEC hub lists recent forms. The stock page is the research view.